Previous Article | Next Article 
Journal of Virology, December 2000, p. 10882-10891, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
An In Vitro Rapid-Turnover Assay for Human Immunodeficiency Virus
Type 1 Replication Selects for Cell-to-Cell Spread of Virus
Suryaram
Gummuluru,
C. Mathew
Kinsey, and
Michael
Emerman*
Divisions of Human Biology and Basic
Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
98109
Received 13 June 2000/Accepted 25 August 2000
We have developed a rapid-turnover culture system where the life
span of a human immunodeficiency virus type 1-infected cell is
controlled by periodic addition of a cytotoxic agent, mitomycin C. These mitomycin C-exposed cells are cocultured with a constant number
of uninfected cells as new targets for the virus. Passage of the
virus-infected cells under these conditions led to the emergence of a
viral variant that was able to replicate efficiently in this culture
system. After biologic and molecular cloning, we were able to identify
a single frameshift mutation in the vpu open reading frame
that was sufficient for growth of the mutant virus in the
rapid-turnover assay. This virus variant spread more efficiently by
cell-to-cell transfer than the parental virus did. Electron micrographs
of cells infected with the
vpu virus revealed a large
number of mature viral capsids attached to the plasma membrane. The
presence of these mature virus particles on the cell surface led to
enhanced fusion and formation of giant syncytia with uninfected cells.
Enhanced cell-to-cell transfer of the
vpu virus provides
an explanation for the survival of this mutant virus in the
rapid-turnover culture system. The in vitro rapid-turnover culture
system is a good representation of the in vivo turnover kinetics of
infected cells and their continual replacement by host lymphopoietic mechanisms.
*
Corresponding author. Mailing address: Divisions of
Human Biology and Basic Sciences, Mailstop C2-023, Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109. Phone: (206) 667-5058. Fax: (206) 667-6523. E-mail:
memerman{at}fhcrc.org.
Journal of Virology, December 2000, p. 10882-10891, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Levin, A., Hayouka, Z., Brack-Werner, R., Volsky, D. J., Friedler, A., Loyter, A.
(2009). Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration. Protein Eng Des Sel
22: 753-763
[Abstract]
[Full Text]
-
Lim, E. S., Emerman, M.
(2009). Simian Immunodeficiency Virus SIVagm from African Green Monkeys Does Not Antagonize Endogenous Levels of African Green Monkey Tetherin/BST-2. J. Virol.
83: 11673-11681
[Abstract]
[Full Text]
-
Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O., Mammano, F.
(2009). Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer. J. Virol.
83: 10527-10537
[Abstract]
[Full Text]
-
Datta, S., Panigrahi, R., Biswas, A., Chandra, P. K., Banerjee, A., Mahapatra, P. K., Panda, C. K., Chakrabarti, S., Bhattacharya, S. K., Biswas, K., Chakravarty, R.
(2009). Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R Mutation. J. Virol.
83: 9983-9992
[Abstract]
[Full Text]
-
Sourisseau, M., Sol-Foulon, N., Porrot, F., Blanchet, F., Schwartz, O.
(2007). Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes. J. Virol.
81: 1000-1012
[Abstract]
[Full Text]
-
Voronin, Y., Overbaugh, J., Emerman, M.
(2005). Simian Immunodeficiency Virus Variants That Differ in Pathogenicity Differ in Fitness under Rapid Cell Turnover Conditions. J. Virol.
79: 15091-15098
[Abstract]
[Full Text]
-
Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., O'Doherty, U.
(2005). Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli. J. Virol.
79: 14179-14188
[Abstract]
[Full Text]
-
Huerta, L., Gomez-Icazbalceta, G., Soto-Ramirez, L., Viveros-Rogel, M., Rodriguez, R., Fuentes, L., Lamoyi, E., Larralde, C.
(2005). Human immunodeficiency virus 1 (HIV-1) envelope-dependent cell-cell fusion modulation by HIV-positive sera is related to disease progression. J. Gen. Virol.
86: 1961-1966
[Abstract]
[Full Text]
-
Lu, C.-W., Roth, M. J.
(2003). Role of the Mutation Q252R in Activating Membrane Fusion in the Murine Leukemia Virus Surface Envelope Protein. J. Virol.
77: 10841-10849
[Abstract]
[Full Text]
-
Komoto, S., Tsuji, S., Ibrahim, M. S., Li, Y.-G., Warachit, J., Taniguchi, K., Ikuta, K.
(2003). The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a Protective Role against Virus-Induced Apoptosis in Primary CD4+ T Lymphocytes. J. Virol.
77: 10304-10313
[Abstract]
[Full Text]
-
Levesque, K., Zhao, Y.-S., Cohen, E. A.
(2003). Vpu Exerts a Positive Effect on HIV-1 Infectivity by Down-modulating CD4 Receptor Molecules at the Surface of HIV-1-producing Cells. J. Biol. Chem.
278: 28346-28353
[Abstract]
[Full Text]
-
Gummuluru, S., KewalRamani, V. N., Emerman, M.
(2002). Dendritic Cell-Mediated Viral Transfer to T Cells Is Required for Human Immunodeficiency Virus Type 1 Persistence in the Face of Rapid Cell Turnover. J. Virol.
76: 10692-10701
[Abstract]
[Full Text]